Hlavičkový papier interný - SVK - Meduni-Wien Aktuell

37Kód štúdie: EFC6269, Alfahydro, 2007-000983-26Žiadateľ: sanofi-aventis, s.r.o.Evropská 2590/33c160 00 Praha 6ČRCentrá:1. Detská FN, Limbová 1, Urologická klinika, 833 40 Bratislava, MUDr.Vladimír Polák2. FN Martin, Kollárova 2, Urologická klinika, 036 59 Martin, prof. MUDr.Ján Kliment............................................................................9012-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy, pharmacodynamic and safety of two doses of alfuzosin (0,1 mg/kg/day; 0,2 mg/kg/day) in the treatment of children and adolescents 2-16 years of age withelevated detrusor leak point pressure of neuropathic etiology followed bya 40-week open-label extensionKód štúdie: EFC5722, Alfachin, 2004-002397-38Žiadateľ: sanofi-aventis, s.r.o.Evropská 2590/33c160 00 Praha 6ČRCentrá:1. Detská FNsP, Limbová 1, Urologická klinika, 833 40 Bratislava, MUDr.Vladimír Polák2. FN Martin, Kollárova 2, Urologická klinika, 036 59 Martin, prof. MUDr.Ján Kliment............................................................................91Bioequivalence study with two products containing sildenafil citrate Sildenafil 100 film-coated tablets and Viagra 100 mg film-coated tablets after single dose to healthy volunteersKód štúdie: S+V/04/07, 2007-003711-31Žiadateľ: hameln rds a.s.Horná 36900 01 ModraSKCentrá:1. hameln rds a.s., Horná 36, Klinické oddelenie, 900 01 Modra, MUDr.Magdaléna Horáková............................................................................92Double-blind, double-dummy, randomised, multi-centre, comparativephase III clinical study on the efficacy and tolerability of an8 week oral treatment with 9 mg budesonide or 3 g mesalazine in patients with active ulcerative colitisKód štúdie: BUC-57/UCA, 2006-005377-22Žiadateľ: Avemedica s.r.o.Zelinárska 8821 08 BratislavaSKCentrá: